Mark A Fletcher

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Community Acquired Pneumonia

Klebsiella Pneumoniae

Top Venues

Expert review of vaccines

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Estelle Méroc, Mark A Fletcher, Germaine Hanquet, Mary P E Slack, Marc Baay, Kyla Hayford, Bradford D Gessner, Lindsay R Grant
Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine. Microorganisms 11 (7) (2023)
Christian Theilacker, Mark A Fletcher, Luis Jodar, Bradford D Gessner
Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022, 10 , 127. Microorganisms 10 (5) (2022)
Juan Manuel Reyes-Sanchez, Jorge LaRotta, Gamboa N Castaño, Mark A Fletcher, Matthew Wasserman, Johnna E Perdrizet, Rodrigo Sini de Almeida
Letter to the editor regarding "Budget impact analysis of pneumococcal conjugate vaccines in Colombia". Expert review of pharmacoeconomics & outcomes research (2021)
Thomas Verstraeten, Mark A Fletcher, Jose A Suaya, Sally Jackson, Cassandra K Hall-Murray, Daniel A Scott, Beate Schmöele-Thoma, Raul E Isturiz, Bradford D Gessner
Diabetes mellitus as a vaccine-effect modifier: a review. Expert review of vaccines 19 (5) (2020)